Comparing Methotrexate vs Pembrolizumab
Methotrexate | Pembrolizumab |
|
---|
Methotrexate | Pembrolizumab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Methotrexate may be considered for the treatment of psoriasis, rheumatoid arthritis, polyarticular juvenile idiopathic arthritis (pJIA), mycosis fungoides, and certain cancers, such as ALL or... View more |
Prescription only
Prescribed for Bladder Cancer, Breast Cancer, Cervical Cancer, Biliary Tract Tumor, Colorectal Cancer, Endometrial Cancer, Esophageal Carcinoma, Gastric Cancer, Head and Neck Cancer, Hepatocellular... View more |
Related suggestions Breast Cancer
Ovarian Cancer
Colorectal Cancer
|
|||||||
More about Methotrexate | More about Pembrolizumab | ||||||||
Ratings & Reviews | |||||||||
Methotrexate has an average rating of 6.5 out of 10 from a total of 336 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 24% reported a negative effect. |
Pembrolizumab has an average rating of 5.2 out of 10 from a total of 281 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Methotrexate side effects |
View all Pembrolizumab side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Methotrexate prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
Jylamvo, Methotrexate LPF Sodium, Otrexup, Rasuvo, Trexall, Xatmep | Keytruda | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
15 hours |
624 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 723 drugs are known to interact with Methotrexate:
|
A total of 589 drugs are known to interact with Pembrolizumab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
December 07, 1953 |
N/A |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
|
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.